If you have been reading about TB-500 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-06-30. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Acetylated heptapeptide form |
| Monoisotopic mass | 888.5 Da | Average mass about 889 Da |
| Appearance | White to off-white solid | Usually supplied as lyophilised powder |
| Solubility class | Highly water soluble | Also dissolves in aqueous buffers |
| Common synonyms | Tbeta4 fragment, thymosin beta-4 (17-23) | Refer to the same sequence |
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
On May 5, 2026, Rubio held a meeting with SOUTHCOM commander General Francis L. Donovan regarding Operation Southern Spear with a map of Cuba on the background. When asked about why he posed a picture with the map of Cuba, he had clarified saying "Cuba is under the Southern Command, you know it's the closest part. Our ambassadors were all over the Western Hemisphere. I met with the general who just took command of SOUTHCOM, and there was a map of Cuba behind us. I thought it would be fitting to take a picture in front of it because it's the closest to the United States within SOUTHCOM.". On May 20, 2026, USS Nimitz (CVN-68) and her Carrier Strike Group along with USS Gridley (DDG-101) and USNS Patuxent had arrived in the Caribbean.
== Early life and education == Fred McLafferty was born in Evanston, Illinois in 1923, but attended grade school in Omaha, Nebraska, graduating from Omaha North High School in 1940. The urgent requirements of World War II accelerated his undergraduate studies at the University of Nebraska; he obtained his B.S. degree in 1943 and thereafter entered the US armed forces. He served in western Europe during the invasion of Germany and was awarded the Combat Infantryman Badge, a Purple Heart, five Bronze Star Medals and a Presidential Unit Citation. He returned to the University of Nebraska in late 1945 and completed his M.S. degree in 1947. He went on to work under William Miller at Cornell University where he earned his Ph.D. in 1950. He went on to a postdoctoral researcher position at the University of Iowa with R.L. Shriner.
=== Influences === The band is influenced to a great extent by English metal music; in 2018, Jerry Cantrell proclaimed Black Sabbath guitarist Tony Iommi as "one of his biggest" inspirations, while Layne Staley named his "first influences" as Black Sabbath and Deep Purple. The group's work with recording engineer Dave Jerden came about because upon meeting the band, recalling: "'Metallica took Tony Iommi and sped him up. What you've done is you've slowed him down again.' And [Cantrell] looked at me and said, 'You got it.' That's how I got the gig. I totally understood what they were doing." Cantrell adjudged English rock singer Elton John as "the artist that made me want to be a musician." In addition, members of Alice in Chains have cited artists including AC/DC, Accept, Aerosmith, the Beatles, Black Flag, David Bowie, John Coltrane, Miles Davis, Dio, Funkadelic, Hanoi Rocks, Heart, Jimi Hendrix, Iron Maiden, Jethro Tull, King's X, Kiss, Led Zeppelin, Lynyrd Skynyrd, Metallica, Steve Miller, Eddie Money, Motörhead, Mudhoney, Ted Nugent, Pink Floyd, the Pixies, Queen, Queensrÿche, the Rolling Stones, Rush, Scorpions, Soundgarden, the Stooges, Television, Thin Lizzy, Robin Trower, U2, UFO, Van Halen, the Velvet Underground, Hank Williams, and ZZ Top as influential or inspirational.
Sources: en.wikipedia.org
=== Industrial production === The hydrolysis of nicotinonitrile is catalysed by the enzyme nitrile hydratase from Rhodococcus rhodochrous J1, producing 3500 tons per annum of nicotinamide for use in animal feed. The enzyme allows for a more selective synthesis as further hydrolysis of the amide to nicotinic acid is avoided. Nicotinamide can also be made from nicotinic acid. According to Ullmann's Encyclopedia of Industrial Chemistry, worldwide 31,000 tons of nicotinamide were sold in 2014.
== Career == Upon receiving his Ph.D., Gattuso moved to Australia where he was a postdoctoral researcher at the Australian Institute of Marine Science(1988-1990). In 1990, Gattuso took a position of CNRS research scientist at Centre de Biologie et Écologie Tropicale et Méditerranéenne of the University of Perpignan (1990-1992). He then moved to the Scientific Center of Monaco to launch and lead the Ecophysiology and Biogeochemistry group. In 1998, Gattuso went back to a CNRS joint laboratory at the Villefranche Oceanographic Observatory and moved to the ranks of Research Professor (directeur de recherche). He is also Associate Scientist at the Institute for Sustainable Development and International Relations (IDDRI-SciencesPo, Paris). Gattuso has been visiting professor or scientist at Rutgers University, the National Center for Atmospheric Research and Shantou University. Gattuso is the founding editor-in-chief of Biogeosciences and served or has served in the editorial board of several scientific journals. He founded the Biogeosciences Division of the European Geosciences Union, and has received multiple awards and honors for his research contributions. He led the launch of the Ocean Acidification International Coordination Centre at the International Atomic Energy Agency, co-edited the first book on ocean acidification (Oxford University Press) and contributed to several IPCC products (5th Assessment Report, Special Report on 1.5°C of Warming, and the Special Report on the Ocean and Cryosphere in a Changing Climate).
== Mode of action == The bird spider O. huwena produces a large amount of toxins which, although often characterized by the presence of ICK motifs, widely differ in their mode of action. Molecularly, the toxin specifically targets the TRPV1 receptor on the outer edge of the outer pore region of the channel. After binding, DkTx will interact with the membrane and insert its hydrophobic residues into the membrane by forming a complex consisting of the membrane and the toxin, which consequently will lock the TRPV1 channel in the open state.
The operation involved 150 aircraft from the United States Navy, Air Force, and Marine Corps. They included airplanes (Lockheed Martin F-22A Raptor, Lockheed Martin F-35A/C Lightning II, Boeing F/A-18E/F Super Hornet, Boeing EA-18G Growler, Grumman E-2D Hawkeye, Rockwell B-1B Lancer) and helicopters (Boeing MH-47G Chinooks and MH-60M DAP), refueling tankers, electronic-warfare (EW) planes, other support aircraft, and numerous unmanned aerial vehicles (including the Lockheed Martin RQ-170 Sentinel). Trump said the United States "had a fighter jet for every possible situation". Following the operation, White House press secretary Karoline Leavitt shared an eyewitness account of Venezuelan military personnel suffering injuries consistent with sonic weaponry during the American strike. Trump later told Katie Pavlich that "we have weapons nobody else knows about [...] we have some amazing weapons. That was an amazing attack." In a separate interview with the New York Post, he referred to one of these as a secret weapon called a "discombobulator," saying it caused Venezuelan defense systems, including Russian and Chinese rockets, to "not work," and that forces "pressed buttons and nothing worked." While Trump suggested the device disrupted equipment, CNN noted that reports of personnel injuries may have involved other technologies, such as acoustic or non-lethal systems such as the Active Denial System, rather than the classified weapon he described. The operation reportedly used one-way attack drones, which is believed to be the first such operational usage by the US military.
Sources: en.wikipedia.org
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.
It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.
Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.
The dry powder is normally kept at -20 °C, protected from light and moisture. Reconstituted solutions are often divided into aliquots and stored at -80 °C to reduce freeze-thaw damage.